Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
 | • レポートコード：MRC308GR10441 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の核放射線治療薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の核放射線治療薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 核放射線治療薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
核放射線治療薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・診断、治療
用途別セグメント
・腫瘍科、甲状腺科、循環器科、その他
主要な市場プレーヤー
・Nihon Medi-Physics Co.,Ltd.、Curium Pharma、Cardinal Health、Bayer Global、GE Healthcare、Mallinckrodt Pharmaceuticals、Bracco Group、Advanced Molecular-imaging Solution、Ciaeriar、Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、核放射線治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な核放射線治療薬メーカーの企業概要、2019年～2022年までの核放射線治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な核放射線治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別核放射線治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの核放射線治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での核放射線治療薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および核放射線治療薬の産業チェーンを掲載しています。
・第14、15章では、核放射線治療薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 核放射線治療薬の概要
– 種類別分析（2018年vs2022年vs2029年）：診断、治療
– 用途別分析（2018年vs2022年vs2029年）：腫瘍科、甲状腺科、循環器科、その他
– 世界の核放射線治療薬市場規模・予測
– 世界の核放射線治療薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Nihon Medi-Physics Co.,Ltd.、Curium Pharma、Cardinal Health、Bayer Global、GE Healthcare、Mallinckrodt Pharmaceuticals、Bracco Group、Advanced Molecular-imaging Solution、Ciaeriar、Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：診断、治療
・用途別分析2018年-2029年：腫瘍科、甲状腺科、循環器科、その他
・核放射線治療薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・核放射線治療薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・核放射線治療薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・核放射線治療薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・核放射線治療薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Nuclear Radiation Therapeutic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Market Analysis by Application
1.4.1 Overview: Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oncology
1.4.3 Thyroid
1.4.4 Cardiology
1.4.5 Others
1.5 Global Nuclear Radiation Therapeutic Drugs
Market Size & Forecast
1.5.1 Global Nuclear Radiation Therapeutic Drugs
Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Nuclear Radiation Therapeutic Drugs
Sales Quantity (2018-2029)
1.5.3 Global Nuclear Radiation Therapeutic Drugs
Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Nihon Medi-Physics Co.,Ltd.
2.1.1 Nihon Medi-Physics Co.,Ltd. Details
2.1.2 Nihon Medi-Physics Co.,Ltd. Major Business
2.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
2.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
2.2 Curium Pharma
2.2.1 Curium Pharma Details
2.2.2 Curium Pharma Major Business
2.2.3 Curium Pharma Nuclear Radiation Therapeutic Drugs
Product and Services
2.2.4 Curium Pharma Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Curium Pharma Recent Developments/Updates
2.3 Cardinal Health
2.3.1 Cardinal Health Details
2.3.2 Cardinal Health Major Business
2.3.3 Cardinal Health Nuclear Radiation Therapeutic Drugs
Product and Services
2.3.4 Cardinal Health Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cardinal Health Recent Developments/Updates
2.4 Bayer Global
2.4.1 Bayer Global Details
2.4.2 Bayer Global Major Business
2.4.3 Bayer Global Nuclear Radiation Therapeutic Drugs
Product and Services
2.4.4 Bayer Global Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Global Recent Developments/Updates
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Nuclear Radiation Therapeutic Drugs
Product and Services
2.5.4 GE Healthcare Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GE Healthcare Recent Developments/Updates
2.6 Mallinckrodt Pharmaceuticals
2.6.1 Mallinckrodt Pharmaceuticals Details
2.6.2 Mallinckrodt Pharmaceuticals Major Business
2.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Product and Services
2.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.7 Bracco Group
2.7.1 Bracco Group Details
2.7.2 Bracco Group Major Business
2.7.3 Bracco Group Nuclear Radiation Therapeutic Drugs
Product and Services
2.7.4 Bracco Group Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bracco Group Recent Developments/Updates
2.8 Advanced Molecular-imaging Solution
2.8.1 Advanced Molecular-imaging Solution Details
2.8.2 Advanced Molecular-imaging Solution Major Business
2.8.3 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Product and Services
2.8.4 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Advanced Molecular-imaging Solution Recent Developments/Updates
2.9 Ciaeriar
2.9.1 Ciaeriar Details
2.9.2 Ciaeriar Major Business
2.9.3 Ciaeriar Nuclear Radiation Therapeutic Drugs
Product and Services
2.9.4 Ciaeriar Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ciaeriar Recent Developments/Updates
2.10 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
2.10.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Details
2.10.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
2.10.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
2.10.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates
3 Competitive Environment: Nuclear Radiation Therapeutic Drugs
by Manufacturer
3.1 Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Manufacturer (2018-2023)
3.2 Global Nuclear Radiation Therapeutic Drugs
Revenue by Manufacturer (2018-2023)
3.3 Global Nuclear Radiation Therapeutic Drugs
Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Nuclear Radiation Therapeutic Drugs
by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Nuclear Radiation Therapeutic Drugs
Manufacturer Market Share in 2022
3.4.2 Top 6 Nuclear Radiation Therapeutic Drugs
Manufacturer Market Share in 2022
3.5 Nuclear Radiation Therapeutic Drugs
Market: Overall Company Footprint Analysis
3.5.1 Nuclear Radiation Therapeutic Drugs
Market: Region Footprint
3.5.2 Nuclear Radiation Therapeutic Drugs
Market: Company Product Type Footprint
3.5.3 Nuclear Radiation Therapeutic Drugs
Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Nuclear Radiation Therapeutic Drugs
Market Size by Region
4.1.1 Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Region (2018-2029)
4.1.2 Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Region (2018-2029)
4.1.3 Global Nuclear Radiation Therapeutic Drugs
Average Price by Region (2018-2029)
4.2 North America Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029)
4.3 Europe Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029)
4.4 Asia-Pacific Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029)
4.5 South America Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029)
4.6 Middle East and Africa Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2029)
5.2 Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Type (2018-2029)
5.3 Global Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2029)
6.2 Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Application (2018-2029)
6.3 Global Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2029)
7 North America
7.1 North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2029)
7.2 North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2029)
7.3 North America Nuclear Radiation Therapeutic Drugs
Market Size by Country
7.3.1 North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2018-2029)
7.3.2 North America Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2029)
8.2 Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2029)
8.3 Europe Nuclear Radiation Therapeutic Drugs
Market Size by Country
8.3.1 Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2018-2029)
8.3.2 Europe Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Nuclear Radiation Therapeutic Drugs
Market Size by Region
9.3.1 Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Nuclear Radiation Therapeutic Drugs
Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2029)
10.2 South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2029)
10.3 South America Nuclear Radiation Therapeutic Drugs
Market Size by Country
10.3.1 South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2018-2029)
10.3.2 South America Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Nuclear Radiation Therapeutic Drugs
Market Size by Country
11.3.1 Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Nuclear Radiation Therapeutic Drugs
Market Drivers
12.2 Nuclear Radiation Therapeutic Drugs
Market Restraints
12.3 Nuclear Radiation Therapeutic Drugs
Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Nuclear Radiation Therapeutic Drugs
and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nuclear Radiation Therapeutic Drugs
13.3 Nuclear Radiation Therapeutic Drugs
Production Process
13.4 Nuclear Radiation Therapeutic Drugs
Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Nuclear Radiation Therapeutic Drugs
Typical Distributors
14.3 Nuclear Radiation Therapeutic Drugs
Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Nihon Medi-Physics Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 4. Nihon Medi-Physics Co.,Ltd. Major Business
Table 5. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
Table 6. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
Table 8. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Curium Pharma Major Business
Table 10. Curium Pharma Nuclear Radiation Therapeutic Drugs
Product and Services
Table 11. Curium Pharma Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Curium Pharma Recent Developments/Updates
Table 13. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 14. Cardinal Health Major Business
Table 15. Cardinal Health Nuclear Radiation Therapeutic Drugs
Product and Services
Table 16. Cardinal Health Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Cardinal Health Recent Developments/Updates
Table 18. Bayer Global Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Global Major Business
Table 20. Bayer Global Nuclear Radiation Therapeutic Drugs
Product and Services
Table 21. Bayer Global Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Global Recent Developments/Updates
Table 23. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. GE Healthcare Major Business
Table 25. GE Healthcare Nuclear Radiation Therapeutic Drugs
Product and Services
Table 26. GE Healthcare Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GE Healthcare Recent Developments/Updates
Table 28. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Mallinckrodt Pharmaceuticals Major Business
Table 30. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Product and Services
Table 31. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 33. Bracco Group Basic Information, Manufacturing Base and Competitors
Table 34. Bracco Group Major Business
Table 35. Bracco Group Nuclear Radiation Therapeutic Drugs
Product and Services
Table 36. Bracco Group Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bracco Group Recent Developments/Updates
Table 38. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
Table 39. Advanced Molecular-imaging Solution Major Business
Table 40. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Product and Services
Table 41. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 43. Ciaeriar Basic Information, Manufacturing Base and Competitors
Table 44. Ciaeriar Major Business
Table 45. Ciaeriar Nuclear Radiation Therapeutic Drugs
Product and Services
Table 46. Ciaeriar Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Ciaeriar Recent Developments/Updates
Table 48. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
Table 50. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
Table 51. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 53. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 54. Global Nuclear Radiation Therapeutic Drugs
Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Nuclear Radiation Therapeutic Drugs
Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Nuclear Radiation Therapeutic Drugs
, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Nuclear Radiation Therapeutic Drugs
Production Site of Key Manufacturer
Table 58. Nuclear Radiation Therapeutic Drugs
Market: Company Product Type Footprint
Table 59. Nuclear Radiation Therapeutic Drugs
Market: Company Product Application Footprint
Table 60. Nuclear Radiation Therapeutic Drugs
New Market Entrants and Barriers to Market Entry
Table 61. Nuclear Radiation Therapeutic Drugs
Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Region (2018-2023) & (Units)
Table 63. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Region (2024-2029) & (Units)
Table 64. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Nuclear Radiation Therapeutic Drugs
Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Nuclear Radiation Therapeutic Drugs
Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2023) & (Units)
Table 69. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2024-2029) & (Units)
Table 70. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Nuclear Radiation Therapeutic Drugs
Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2023) & (Units)
Table 75. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2024-2029) & (Units)
Table 76. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Nuclear Radiation Therapeutic Drugs
Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2023) & (Units)
Table 81. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2024-2029) & (Units)
Table 82. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2023) & (Units)
Table 83. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2024-2029) & (Units)
Table 84. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2018-2023) & (Units)
Table 85. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2024-2029) & (Units)
Table 86. North America Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2023) & (Units)
Table 89. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2024-2029) & (Units)
Table 90. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2023) & (Units)
Table 91. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2024-2029) & (Units)
Table 92. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2018-2023) & (Units)
Table 93. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2024-2029) & (Units)
Table 94. Europe Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2023) & (Units)
Table 97. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2024-2029) & (Units)
Table 98. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2023) & (Units)
Table 99. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2024-2029) & (Units)
Table 100. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Region (2018-2023) & (Units)
Table 101. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity by Region (2024-2029) & (Units)
Table 102. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2023) & (Units)
Table 105. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2024-2029) & (Units)
Table 106. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2023) & (Units)
Table 107. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2024-2029) & (Units)
Table 108. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2018-2023) & (Units)
Table 109. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity by Country (2024-2029) & (Units)
Table 110. South America Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Nuclear Radiation Therapeutic Drugs
Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2018-2023) & (Units)
Table 113. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Type (2024-2029) & (Units)
Table 114. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2018-2023) & (Units)
Table 115. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Application (2024-2029) & (Units)
Table 116. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Region (2018-2023) & (Units)
Table 117. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity by Region (2024-2029) & (Units)
Table 118. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Nuclear Radiation Therapeutic Drugs
Raw Material
Table 121. Key Manufacturers of Nuclear Radiation Therapeutic Drugs
Raw Materials
Table 122. Nuclear Radiation Therapeutic Drugs
Typical Distributors
Table 123. Nuclear Radiation Therapeutic Drugs
Typical Customers
List of Figures
Figure 1. Nuclear Radiation Therapeutic Drugs
Picture
Figure 2. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Type in 2022
Figure 4. Diagnostic Examples
Figure 5. Therapeutic Examples
Figure 6. Global Nuclear Radiation Therapeutic Drugs
Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Application in 2022
Figure 8. Oncology Examples
Figure 9. Thyroid Examples
Figure 10. Cardiology Examples
Figure 11. Others Examples
Figure 12. Global Nuclear Radiation Therapeutic Drugs
Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Nuclear Radiation Therapeutic Drugs
Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity (2018-2029) & (Units)
Figure 15. Global Nuclear Radiation Therapeutic Drugs
Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Nuclear Radiation Therapeutic Drugs
by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Nuclear Radiation Therapeutic Drugs
Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Nuclear Radiation Therapeutic Drugs
Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Region (2018-2029)
Figure 54. China Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Nuclear Radiation Therapeutic Drugs
Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Nuclear Radiation Therapeutic Drugs
Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Nuclear Radiation Therapeutic Drugs
Market Drivers
Figure 75. Nuclear Radiation Therapeutic Drugs
Market Restraints
Figure 76. Nuclear Radiation Therapeutic Drugs
Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Nuclear Radiation Therapeutic Drugs
in 2022
Figure 79. Manufacturing Process Analysis of Nuclear Radiation Therapeutic Drugs
Figure 80. Nuclear Radiation Therapeutic Drugs
Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source